The data set from the double-blind phase of the RewinD-LB trial presented today at ILBDC is now accessible in the Investor section o the CervoMed website https://www.cervomed.com/.

A new study suggests that electrocardiogram (ECG) tests, combined with artificial intelligence (AI), could one day help ...